Climb Bio appoints Breanna O’Reilly to Board as Andrew Levin resigns

Climb Bio appointed Breanna O’Reilly, Ph.D. to its Board effective June 29, 2026, following the resignation of director Andrew Levin.Original SEC Filing: Climb Bio, Inc. [ CLYM ] - 8-K - Jul. 01, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important informatio…

Climb Bio appointed Breanna O’Reilly, Ph.D. to its Board effective June 29, 2026, following the resignation of director Andrew Levin.

IndividualAndrew LevinBreanna O’Reilly, Ph.D.

RoleDirectorDirector (non-employee)

Type of ChangeResignedAppointed / Elected

Effective DateJune 29, 2026June 29, 2026

ReasonNot disclosedNot disclosed

Replacement InfoReplaced by Breanna O’Reilly, Ph.D.Replaces Andrew Levin

Background DetailsNot disclosedWill receive non-employee director compensation; granted option for 70,284 shares at $13.36/share vesting monthly over 3 years; $40,000 annual cash retainer; annual equity grants

Board/Committee Role ChangesNot disclosedNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.